Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis

Journal of B.U.ON.

Volumn 16, Issue 2, 2011, Pages 277-281

  Pecic, Vanja ^a   Stankovic Djordjevic, D ^b   Nestorovic, M ^a   Radojkovic, M ^a   Marjanovic, H ^a   Illic, B ^a   Milojkovic, M ^a  

^a CLINICAL CENTER NIS   (Serbia)

^b Institute for Public Health   (Serbia)

Author keywords

Genotype; Hepatitis C virus; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79960277167     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543.
2. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni Jr. JF. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290-296. (Pubitemid 32911426)
3. Gao YH, Jiang QW, Zhou XF et al. HBV infection and familial aggregation of liver cancer: an analysis of case-control family study. Cancer Causes Control 2004; 15: 845-850.
4. Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 2001; 313: 15-19. (Pubitemid 33016686)
5. Tang ZY. Primary hepatocellular carcinoma. In: Tang ZY (Ed). Contemporary Oncology (Chinese). Shanghai7, Shanghai Medical University, 1993, pp 554-585.
6. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160: 3227-3230.
7. Bayati N, Silverman AL, Gordon SC. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol 1998; 93: 2452-2456. (Pubitemid 29018554)
8. Stroffolini T, Andreone P, Andriulli A et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998; 29: 944-952.
9. Stroffolini T, Chiaramonte M, Tiribelli C et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360-363. (Pubitemid 23013231)
10. Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-2137. (Pubitemid 29215551)
11. Simonetti RG, Camma C, Fiorello F et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97-102.
12. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000; 31: 241-246. (Pubitemid 30033714)
13. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19: 3-23. (Pubitemid 40331495)
14. Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 2007; 46: 1350-1356.
15. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-236.
16. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15: 948-963.
17. Degos F, Christidis C, Gann-Carrie N et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131-136. (Pubitemid 30430422)
18. Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-2137. (Pubitemid 29215551)
19. Sánchez BC, Ferrer DJ, Vargas RR et al. Clinical-epidemiological characteristics of hepatocellular carcinoma and treatment in the department of digestive system diseases of the National Hospital "Eduardo Rebagliatti Martins". Rev Gastroenterol Peru 2009; 29: 17-23.
20. Strader D, Wright T, Thomas D, Seeff L. Diagnosis, menagement and treatment of hepatitis C. Hepatology 2004; 39: 1147-1171.
21. Forns X, Bukh J. The molecular biology of hepatitis C. Clin Liver Dis 1999; 3: 125-130.
22. Shibata M, Morizane T, Uchida T et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis C virus infection. Lancet 1998; 351: 1773-1777. (Pubitemid 28269188)
23. Miyamura T. Analysis of hepatitis C virus genome and hepatocellular carcinoma. In: Brechot C (Ed): Primary liver cancer, etiological and progression factors. London: CRC Press, 1994, pp 125-136.
24. Colombo M, Romero R. Hepatitis C virus infection and hepatocellular carcinoma. In: Brechot C (Ed): Primary liver cancer, etiological and progression factors. London: CRC Press, 1994, pp 49-55.
25. Saeian K, Reddy RK. Hepatitis C cirrhosis-not necessarily a terminal disease. Am J Gastroenterol 1998; 93: 1386-1387.
26. Davcev P, Bidikov V, Stavric D et al. Characteristics of hepatocellular carcinoma in the non-cirrhotic liver. Med Pregl 1990; 43: 457-461.
27. Simmonds P, Bukh J, Combet C et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-973. (Pubitemid 41401136)
28. Silini E, Botteli R, Asti M et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study. Gastroenterology 1996; 111: 199-205. (Pubitemid 26226900)
29. De Mitri MS, Poussin K, Baccarini P et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345: 413-415.
30. Akkiz H, Colakoglu S, Koksal F et al. Hepatitis C virus genotypes in patients with hepatocellular carcinoma. J Environ Pathol Toxicol Oncol 1996; 15: 85-88. (Pubitemid 27280392)
31. Bruno S, Silini E, Crosignani et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25: 754-758. (Pubitemid 27106466)
32. Tagger A, Donato F, Ribero M et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Int J Cancer 1999; 81: 695-699. (Pubitemid 29214375)
33. Reid AE, Koziel MJ, Aiza I et al. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States. Am J Gastroenterol 1999; 94: 1619-1626. (Pubitemid 29260455)
34. Benvengnu L, Pontisso P, Cavalletto D, Noventa F, Chemallo L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25: 211-215. (Pubitemid 27015012)
35. Romeo R, Rumi M, Del Nino E, Colombo M. Hepatitis C virus genotype 1 b and risk of hepatocellular carcinoma. Hepatology 1997; 26: 1077. (Pubitemid 27413682)
36. Yotsuyanagi H, Koike K, Yusida K et al. Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 1995; 76: 1352-1355.
37. Silini EM, Bono F, Cividini A et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285-290.
38. Feray C, Gigou M, Samue D et al. Influence of genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088-1096.
39. Hino K, Sainokami S, Shimoda K et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299-305. (Pubitemid 24131401)
40. Tsubota A, Shayma K, Ikeda K et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-1094. (Pubitemid 24134229)
41. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-699.
42. Ray RB, Lagging LM, Mayer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblast to tumorigenic phenotype. J Virol 1996; 70: 4438-4443. (Pubitemid 26187445)
43. Isido S, Hotta H. Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett 1998; 438: 258-262. (Pubitemid 28529285)
44. Kwun HJ, Jung EY, Achn JY et al. P53 dependent transcriptional repression of p21(wafl) by hepatitis C virus NS3. J Gen Virol 2001; 82: 2235-2241. (Pubitemid 32827604)
45. Quadri I, Yvanashi M, Sikmon F. Hepatitis C virus NS5a protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC 3. Biochem Biophys Acta 2002; 1592: 193-204.
46. Brechot C, Jaffredo F, Lagorce D et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998; 173-183. (Pubitemid 28352801)
47. Nishioka K, Watanabe J, Furata S et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 2: 429-433.